Clinical Trials Browser

Phase 3 × INDUSTRY × SH-1028 × Clear all

NCT06080776 2023-10-12

SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung